Oncolytic immunotherapies specialist Replimune Group has announced that the US Food and Drug Administration (FDA) has ...

South Korea’s SK Biopharmaceuticals (KRX: 326030) has partnered with Brazil’s Eurofarma to launch Mentis Care, a ...

Aspire Pharma, a rapidly growing UK-based specialty generics business, has announced the acquisition of Charlwood Pharma, a ...

US trade group the Research and Manufacturers of America (PhRMA) has hailed the impact of direct purchase programs (DPPs), ...

South Korea-based Samsung Bioepis and Chinese biotech start-up Phrontline Biopharma have entered into a global collaboration ...

US contract manufacturer Life Science Outsourcing has appointed Doug Constable as chief executive to steer its next growth ...

Swiss pharma giant Roche’s US subsidiary Genentech yesterday revealed that the US Food and Drug Administration (FDA) has ...

Summit Therapeutics (Nasdaq: SMMT) said it plans to file a biologics license application in the fourth quarter for ...

Five months after closing its Series B financing, USA-based NewLimit has raised an additional $45 million from Eli Lilly), ...

Israeli pharma major Teva (NYSE: TEVA) has entered a licensing agreement with Singapore-based Prestige Biopharma (KOSDAQ: ...

Following an extensive review, Belgian biotech Galapagos today revealed its intention to wind down its cell therapy business ...

California, USA-based Alto Neuroscience saw its shares shoot up more than 80% to $11.00 yesterday, after it revealed it has ...